Hang Lak Lee

10PUBLICATIONS
101CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsPharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Clinical chemistry (incl. diagnostics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 20, 2026
Co-administration of calcium carbonate or sodium bicarbonate prevents esomeprazole-induced osteoporosis.

|Jan 16, 2026
Randomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric Ulcers.

Kyung Sik Park, Hyun-Soo Kim, Jung-Hwan Oh

|Jul 08, 2024
Randomized, Double-Blind, Active-Controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan Compared With Esomeprazole in Erosive Esophagitis.

Jung-Hwan Oh, Hyun-Soo Kim, Dae Young Cheung

|Feb 22, 2024
The Effect of Tegoprazan on the Treatment of Endoscopic Resection-Induced Artificial Ulcers: A Multicenter, Randomized, Active-Controlled Study.

Byung-Wook Kim, Jong Jae Park, Hee Seok Moon

|Jul 06, 2022
Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial.

Yoon Jin Choi, Yong Chan Lee, Jung Mogg Kim

|Apr 08, 2021
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 Study.

Gwang Ha Kim, Hang Lak Lee, Moon Kyung Joo

Pageof 2

Frequent Collaborators

4 joint publications

Gwang Ha Kim

4 joint publications

Byung-Wook Kim

3 joint publications

Gwang Ho Baik

3 joint publications

Ki-Nam Shim